Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Becton DickinsonBDX +0.79%77 EV-to-OCF is 20.25 as of Aug. 16, 2026, which is 4% above its 10-year median of 19.45. GuruFocus rates BDX with a GF Score™ of 77/100 and a GF Value™ of $191.40 (Fairly Valued). The stock has 7 warning signs investors should review. Among 851 Medical Devices & Instruments companies, Becton Dickinson ranks worse than 75.91% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Becton Dickinson's Enterprise Value is $66,055 Mil.
Becton Dickinson's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was $3,262 Mil. Therefore, Becton Dickinson's EV-to-OCF for today is 20.25.
The historical rank and industry rank for Becton Dickinson's EV-to-OCF or its related term are showing as below:
BDX'
s EV-to-OCF Range Over the Past 10 Years
Min: 13.23 Med: 19.45 Max: 36.02
Current: 20.25
During the past 13 years, the highest EV-to-OCF of Becton Dickinson was 36.02. The lowest was 13.23. And the median was 19.45.
BDX's EV-to-OCF is ranked worse than 75.91% of 851
companies
in the Medical Devices & Instruments industry
Industry Median: 7.82
vs BDX: 20.25
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Becton Dickinson's PE Ratio (TTM) for today is calculated as:
Becton Dickinson's share price for today is $183.40.
Becton Dickinson's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.320.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Becton Dickinson EV-to-OCF Related Terms
Becton Dickinson EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Becton Dickinson's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Becton Dickinson's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Becton Dickinson EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Becton Dickinson's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Becton Dickinson's EV-to-OCF falls into.
Becton Dickinson's current Enterprise Value is $66,055 Mil.
Becton Dickinson's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $3,262 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Becton Dickinson (BDX) has a EV-to-OCF of 20.25 as of Aug. 16, 2026. This is near median its historical median of 19.45. Over the past decade, Becton Dickinson's EV-to-OCF has ranged from 13.23 to 36.02. According to the industry distribution chart, Becton Dickinson ranks #646 out of 851 companies in the Medical Devices & Instruments industry, placing it in the top 75.9%.
Is Becton Dickinson's EV-to-OCF too high?
Becton Dickinson's current EV-to-OCF of 20.25 is near median its 10-year median of 19.45. Over the past 10 years, this metric has ranged from a low of 13.23 to a high of 36.02. The Medical Devices & Instruments industry median EV-to-OCF is 7.82. Becton Dickinson's value of 20.25 is 159% above this industry median. Based on the distribution chart, Becton Dickinson ranks #646 out of 851 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Becton Dickinson has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Becton Dickinson's EV-to-OCF compare to MDLN and RMD?
According to the Medical Devices & Instruments industry distribution chart, Becton Dickinson ranks #646 out of 851 companies for EV-to-OCF. This places Becton Dickinson in the lower half of its industry. The industry median EV-to-OCF is 7.82. Becton Dickinson's value of 20.25 is 159% above this benchmark. Historically, Becton Dickinson's own EV-to-OCF has ranged from 13.23 to 36.02 over the past decade. While the company's 10-year median is 19.45 vs. the industry median of 7.82, Becton Dickinson has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.82, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Becton Dickinson's current EV-to-OCF of 20.25 is 159% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Becton Dickinson's current EV-to-OCF is 20.25, which is near median its own 10-year median of 19.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Becton Dickinson stock overvalued right now?
Based on GuruFocus' analysis, Becton Dickinson (BDX) is currently considered Fairly Valued. The stock's GF Value™ is $191.40, compared to a current price of $183.40 — trading 4.2% below its estimated fair value. The current EV-to-OCF is 20.25, which is near median its 10-year median of 19.45 and 159% above the Medical Devices & Instruments industry median of 7.82. Becton Dickinson's overall GF Score™ is 77/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Becton Dickinson (BDX), the current EV-to-OCF is 20.25 as of Aug. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Becton Dickinson (BDX) Overvalued in 2026?
Based on GuruFocus' analysis, Becton Dickinson stock appears to be undervalued.
The current stock price of $183.40 is trading 4.2% below its estimated GF Value™ of $191.40.
GuruFocus considers Becton Dickinson to be Fairly Valued.
Key valuation signals for BDX:
EV-to-OCF: 20.25 (near median its 10-year median of 19.45)
GF Value™: $191.40 vs. price of $183.40 (4.2% below fair value)
Industry Position: 159% above the Medical Devices & Instruments median (#646 of 851)
No single metric tells the full story. See the BDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
77GF Score
Get the complete analysis for BDX
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BDX has been successfully added to your 
